title: Real-world evidence supports optimally dosed thiazide-type diuretics as preferred in treatment regimens of older adults with hypertension.
authors.affiliation: Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: Paula T
authors.initials: PT
authors.lastname: Einhorn
authors.affiliation: School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.
authors.forename: Paul K
authors.initials: PK
authors.lastname: Whelton
authors.affiliation: Coordinating Center for Clinical Trials, School of Public Health, University of Texas, Houston, Texas.
authors.forename: Barry R
authors.initials: BR
authors.lastname: Davis
authors.affiliation: Clinical Hypertension Program, University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Jackson T
authors.initials: JT
authors.lastname: Wright
authors.affiliation: Veterans Affairs Medical Center, University of Tennessee Health Science Center, Memphis, Tennessee.
authors.forename: William C
authors.initials: WC
authors.lastname: Cushman
authors.affiliation: Division of Geriatrics and Clinical Gerontology, National Institute on Aging, National Institutes of Health, Bethesda, Maryland.|for the ALLHAT Collaborative Research Group.
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Zieman
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008659:Metabolic Diseases / Q000139:chemically induced*; D049971:Thiazides / Q000009:adverse effects*
chemical_list: D000959:Antihypertensive Agents; D049971:Thiazides